These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 33334865)

  • 21. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
    Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
    BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Risk Factors Among Patients Infected with COVID-19 in Saudi Arabia.
    Alshaikh MK; Alotair H; Alnajjar F; Sharaf H; Alhafi B; Alashgar L; Aljuaid M
    Vasc Health Risk Manag; 2021; 17():161-168. PubMed ID: 33907410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Burden of Cardiovascular Disease Risk Factors in the Middle East: A Systematic Review and Meta-Analysis Focusing on Primary Prevention.
    Bhagavathula AS; Shehab A; Ullah A; Rahmani J
    Curr Vasc Pharmacol; 2021; 19(4):379-389. PubMed ID: 32525775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews.
    Studziński K; Tomasik T; Krzysztoń J; Jóźwiak J; Windak A
    BMC Cardiovasc Disord; 2019 Jan; 19(1):11. PubMed ID: 30626326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
    Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
    Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Hall EJ; Ayers CR; Kolkailah AA; Rutan C; Walchok J; Williams JH; Wang TY; Rodriguez F; Bradley SM; Stevens L; Hall JL; Mallya P; Roth GA; Morrow DA; Elkind MSV; Das SR; de Lemos JA
    Circ Cardiovasc Qual Outcomes; 2023 May; 16(5):e009652. PubMed ID: 37017087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular diseases as risk factors of post-COVID syndrome: a systematic review.
    Sha'ari NI; Ismail A; Abdul Aziz AF; Suddin LS; Azzeri A; Sk Abd Razak R; Mad Tahir NS
    BMC Public Health; 2024 Jul; 24(1):1846. PubMed ID: 38987743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of occupational exposure to noise on ischaemic heart disease, stroke and hypertension: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-Related Burden of Disease and Injury.
    Teixeira LR; Pega F; Dzhambov AM; Bortkiewicz A; da Silva DTC; de Andrade CAF; Gadzicka E; Hadkhale K; Iavicoli S; Martínez-Silveira MS; Pawlaczyk-Łuszczyńska M; Rondinone BM; Siedlecka J; Valenti A; Gagliardi D
    Environ Int; 2021 Sep; 154():106387. PubMed ID: 33612311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the Coexistence of Somnipathy and Diabetes With the Risks of Cardiovascular Disease Events, Stroke, and All-Cause Mortality: A Systematic Review and Meta-analysis.
    Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
    J Am Heart Assoc; 2022 Jul; 11(14):e024783. PubMed ID: 35861844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orthostatic hypertension and major adverse events: a systematic review and meta-analysis.
    Pasdar Z; De Paola L; Carter B; Pana TA; Potter JF; Myint PK
    Eur J Prev Cardiol; 2023 Aug; 30(10):1028-1038. PubMed ID: 37202364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease.
    Tessitore E; Carballo D; Poncet A; Perrin N; Follonier C; Assouline B; Carballo S; Girardin F; Mach F
    Open Heart; 2021 Apr; 8(1):. PubMed ID: 33833064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
    Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erectile Dysfunction Predicts Cardiovascular Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis.
    Zhao B; Hong Z; Wei Y; Yu D; Xu J; Zhang W
    J Sex Med; 2019 Jul; 16(7):1005-1017. PubMed ID: 31104857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh.
    Sharif N; Ahmed SN; Opu RR; Tani MR; Dewan D; Daullah MU; Shanto RI; Parvez AK; Talukder AA; Dey SK
    Diabetes Metab Syndr; 2021; 15(3):1009-1016. PubMed ID: 33993046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and impact of cardiac injury on COVID-19: A systematic review and meta-analysis.
    Fu L; Liu X; Su Y; Ma J; Hong K
    Clin Cardiol; 2021 Feb; 44(2):276-283. PubMed ID: 33382482
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.